Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive continuous treatment to live better, longer.
Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are the most common blood cancers in the United States. There is no treatment to help people with CLL to stay in remission, and while advances in treatment have provided people with MM a multitude of treatment options, they struggle with long-term tolerance of high doses, which may be more effective but come with a multitude of side effects.
Starton’s team of some of the best in clinical development and hematology/oncology have come together to change the fate for people struggling with the impact of their diseases. If dose-related side effects can be reduced and people can tolerate maintenance therapy for decades to help stay in remission, these cancers – which were previously a death sentence – would become more akin to chronic diseases, with a long lifespan and healthy quality of life.
Starton is one of the few life sciences companies funded exclusively by individual investors. We have a business model that is lower risk, faster to market and less capital intensive than biotech companies developing medicines from scratch.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 215 College Rd,
- Phone
- +1 800 449 5405
- co****@****io.care
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- startontx.com
- HQ
- Paramus, New Jersey
Starton Therapeutics Questions
Starton Therapeutics's helpline number is +1 800 449 5405
Starton Therapeutics's website is startontx.com
Starton Therapeutics's LinkedIn profile is https://www.linkedin.com/company/startontx
Starton Therapeutics has
13 employees.
View email and phone details for 13
employees at Starton Therapeutics.
Starton Therapeutics's industry is
Biotechnology Research
Starton Therapeutics's top competitors are
Newyorkbio,
Next Big Innovation Labs®,
Fesarius Therapeutics,
Bd,
Bend Bioscience,
Pfizer,
Calder Biosciences Inc.,
Cresilon,
Regeneron,
Epibone, Inc..
Starton Therapeutics's support email address is contact@chemio.care
Starton Therapeutics's categories are Biotechnology Research
Starton Therapeutics's founding year is 2017
